-
Je něco špatně v tomto záznamu ?
Modulators of 14-3-3 Protein-Protein Interactions
LM. Stevers, E. Sijbesma, M. Botta, C. MacKintosh, T. Obsil, I. Landrieu, Y. Cau, AJ. Wilson, A. Karawajczyk, J. Eickhoff, J. Davis, M. Hann, G. O'Mahony, RG. Doveston, L. Brunsveld, C. Ottmann,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- lidé MeSH
- objevování léků metody MeSH
- proteiny 14-3-3 antagonisté a inhibitory metabolismus MeSH
- stabilita proteinů účinky léků MeSH
- vazba proteinů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein-protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as "undruggable" targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.
GlaxoSmithKline Gunnels Wood Road Stevenage Hertfordshire SG1 2NY United Kingdom
Lead Discovery Center GmbH Dortmund 44227 Germany
Taros Chemicals GmbH and Co KG Dortmund 44227 Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028736
- 003
- CZ-PrNML
- 005
- 20190823093918.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.7b00574 $2 doi
- 035 __
- $a (PubMed)28968506
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stevers, Loes M $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS) , Eindhoven University of Technology , P.O. Box 513, 5600 MB , Eindhoven , The Netherlands.
- 245 10
- $a Modulators of 14-3-3 Protein-Protein Interactions / $c LM. Stevers, E. Sijbesma, M. Botta, C. MacKintosh, T. Obsil, I. Landrieu, Y. Cau, AJ. Wilson, A. Karawajczyk, J. Eickhoff, J. Davis, M. Hann, G. O'Mahony, RG. Doveston, L. Brunsveld, C. Ottmann,
- 520 9_
- $a Direct interactions between proteins are essential for the regulation of their functions in biological pathways. Targeting the complex network of protein-protein interactions (PPIs) has now been widely recognized as an attractive means to therapeutically intervene in disease states. Even though this is a challenging endeavor and PPIs have long been regarded as "undruggable" targets, the last two decades have seen an increasing number of successful examples of PPI modulators, resulting in growing interest in this field. PPI modulation requires novel approaches and the integrated efforts of multiple disciplines to be a fruitful strategy. This perspective focuses on the hub-protein 14-3-3, which has several hundred identified protein interaction partners, and is therefore involved in a wide range of cellular processes and diseases. Here, we aim to provide an integrated overview of the approaches explored for the modulation of 14-3-3 PPIs and review the examples resulting from these efforts in both inhibiting and stabilizing specific 14-3-3 protein complexes by small molecules, peptide mimetics, and natural products.
- 650 _2
- $a proteiny 14-3-3 $x antagonisté a inhibitory $x metabolismus $7 D048948
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a objevování léků $x metody $7 D055808
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a stabilita proteinů $x účinky léků $7 D055550
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Sijbesma, Eline $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS) , Eindhoven University of Technology , P.O. Box 513, 5600 MB , Eindhoven , The Netherlands.
- 700 1_
- $a Botta, Maurizio $u Department of Biotechnology, Chemistry and Pharmacy , University of Siena , Via Aldo Moro 2 , 53100 Siena , Italy.
- 700 1_
- $a MacKintosh, Carol $u Division of Cell and Developmental Biology, School of Life Sciences , University of Dundee , Dundee DD1 4HN , United Kingdom.
- 700 1_
- $a Obsil, Tomas $u Department of Physical and Macromolecular Chemistry, Faculty of Science , Charles University , Prague 116 36 , Czech Republic.
- 700 1_
- $a Landrieu, Isabelle $u Université deLille, CNRS, UMR 8576 , F 59 000 Lille , France.
- 700 1_
- $a Cau, Ylenia $u Department of Biotechnology, Chemistry and Pharmacy , University of Siena , Via Aldo Moro 2 , 53100 Siena , Italy.
- 700 1_
- $a Wilson, Andrew J $u School of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , United Kingdom. Astbury Center For Structural Molecular Biology , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , United Kingdom.
- 700 1_
- $a Karawajczyk, Anna $u Taros Chemicals GmbH & Co. KG , Dortmund 44227 , Germany.
- 700 1_
- $a Eickhoff, Jan $u Lead Discovery Center GmbH , Dortmund 44227 , Germany.
- 700 1_
- $a Davis, Jeremy $u UCB Celltech , 216 Bath Road , Slough SL1 3WE , United Kingdom.
- 700 1_
- $a Hann, Michael $u GlaxoSmithKline , Gunnels Wood Road , Stevenage, Hertfordshire SG1 2NY , United Kingdom.
- 700 1_
- $a O'Mahony, Gavin $u Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit , AstraZeneca Gothenburg , Pepparedsleden 1 , SE-431 83 Mölndal , Sweden.
- 700 1_
- $a Doveston, Richard G $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS) , Eindhoven University of Technology , P.O. Box 513, 5600 MB , Eindhoven , The Netherlands.
- 700 1_
- $a Brunsveld, Luc $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS) , Eindhoven University of Technology , P.O. Box 513, 5600 MB , Eindhoven , The Netherlands.
- 700 1_
- $a Ottmann, Christian $u Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems (ICMS) , Eindhoven University of Technology , P.O. Box 513, 5600 MB , Eindhoven , The Netherlands. Department of Chemistry , University of Duisburg-Essen , Universitätstraße 7 , 45141 Essen , Germany.
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 61, č. 9 (2018), s. 3755-3778
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28968506 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190823094132 $b ABA008
- 999 __
- $a ok $b bmc $g 1433885 $s 1067196
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 61 $c 9 $d 3755-3778 $e 20171019 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20190813